Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer

Ameya D. Puranik,Sayak Choudhury,Suchismita Ghosh,Indraja D. Dev,Varun Ramchandani,Abhishek Uppal,Vikrant Bhosale,Abhishek Palsapure,Rachita Rungta,Rakesh Pandey,Shweta Khatri,Gemson George,Yogesh Satamwar,Rahul Maske,Archi Agrawal,Sneha Shah,Nilendu C. Purandare,Venkatesh Rangarajan
DOI: https://doi.org/10.4103/ijc.ijc_52_24
2024-01-01
Indian Journal of Cancer
Abstract:Abstract PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it’s way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.
oncology
What problem does this paper attempt to address?